The defence used by the JLP, oftentimes highlighted by an in-your-face Daryl Vaz, is that PNP President Mark Golding and his ...

So says Peter Lynch, who made it his mantra while successfully managing Fidelity Investment’s Magellan Fund FMAGX between 1977 and 1990, averaging a 29.2% annual return and consistently outperforming ...

Lynch syndrome affects 1 in 279 Americans, increasing cancer risk and highlighting the need for genetic testing and preventive measures. Previvors navigate a complex emotional landscape, balancing ...

You might not have seen a case of it yet, but odds are increasing that a patient with an emerging meat allergy could present to your clinic. Alpha-gal syndrome (AGS), the tick-borne allergy to animal ...

On Sunday afternoon, the San Francisco 49ers picked up their first loss of the season with a close home defeat at the hands of the Jacksonville Jaguars. The game marked the return of quarterback Brock ...

The final, formatted version of the article will be published soon. Metachronous colorectal cancers (mCRC) occur in ~3.4% of cases within 10 years of initial diagnosis, with risks elevated in ...

Clarksville Academy senior Willie Wilson was voted the Leaf-Chronicle's top high school football defensive player at midseason. Wilson, who had 23 tackles and three TFLs in his first five games, ...

The filmmaker produced some of his most memorable works there. Also, the pop star Sabrina Carpenter reportedly bought a penthouse and the lake home of Jim Irsay, owner of the Indianapolis Colts, is ...

See photos of Ian Perkins, the sole person to ever see the walls of a prison cell for involvement in the Bitter Blood killings 40 years ago. Ian Mark Perkins cries while testifying in court as an ...

Below is Validea's guru fundamental report for UNITED PARCEL SERVICE INC (UPS). Of the 22 guru strategies we follow, UPS rates highest using our P/E/Growth Investor model based on the published ...

(RTTNews) - Tonix Pharmaceuticals Holding Corp. (TNXP) on Monday said it plans to start a Phase 2 study of TNX-2900 for the treatment of Prader-Willi syndrome, a genetic disorder that affects multiple ...

Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with Prader-Willi Syndrome under a cleared IND TNX-2900 ...